Commercialization·Colorectal cancer
DTPx Therapeutics won $100,000 from FACIT to develop a new treatment by targeting hibernating cancer cells. For many people with colorectal cancer, treatment can be a vicious cycle. Even when it looks like chemotherapy killed…
Article·